Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis.
The efficacy of azithromycin or clarithromycin was compared to that of amoxicillin, clindamycin, or erythromycin for the prevention of viridans group streptococcus experimental endocarditis. Rabbits with catheter-induced aortic valve vegetations were given no antibiotics or two doses of amoxicillin at 25 mg/kg of body weight, azithromycin at 10 mg/kg, clarithromycin at 10 mg/kg, clindamycin at 40 mg/kg followed by clindamycin at 20 mg/kg, or erythromycin at 10 mg/kg. Antibiotics were administered 0.5 h before and 5.5 h after intravenous infusion of 5 x 10(5) CFU of Streptococcus milleri. Forty-eight hours after bacterial inoculation, the rabbits were killed and aortic valve vegetations were aseptically removed and cultured for bacteria. Infective endocarditis occurred in 88% of untreated animals, 1% of animals receiving amoxicillin, 9% of animals receiving erythromycin, 0% of animals receiving clindamycin, 2.5% of animals receiving clarithromycin, and 1% of animals receiving azithromycin. All five regimens were more effective (P < 0.001) than no prophylaxis. Erythromycin was less effective (P < 0.05) than amoxicillin or clindamycin. Azithromycin or clarithromycin was as effective as amoxicillin, clindamycin, or erythromycin for the prevention of viridans group streptococcus experimental endocarditis in this model.
Rouse
M S
MS
Infectious Diseases Research Laboratory, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
Steckelberg
J M
JM
Brandt
C M
CM
Patel
R
R
Miro
J M
JM
Wilson
W R
WR
D000658:Amoxicillin / Q000097:blood / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000097:blood / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D017963:Azithromycin / Q000097:blood / Q000627:therapeutic use*; D017291:Clarithromycin / Q000097:blood / Q000627:therapeutic use*; D002981:Clindamycin / Q000097:blood / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000097:blood / Q000382:microbiology / Q000517:prevention & control*; D004917:Erythromycin / Q000097:blood / Q000627:therapeutic use; D011817:Rabbits; D013291:Streptococcus / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D002981:Clindamycin; D004917:Erythromycin; D000658:Amoxicillin; D017963:Azithromycin; D017291:Clarithromycin